PlainPharmaWatch

CMS Open Payments · Program Year 2024

Cgg Medical Inc

Cgg Medical Inc reported $149,710.86 across General Payments, Research, and Ownership to 647 physicians and teaching hospitals across 647 transactions.

$149.7K
All-tracks total
647
Transactions
647
Recipients
+$11.8K
General Payments vs PY2023

Cgg Medical Inc reported $149,710.86 across all CMS Open Payments tracks (General + Research + Ownership) to 647 physicians and teaching hospitals in Program Year 2024 - ranking #1082 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $149,710.86, averaging $231.39 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer cgg-medical-inc Cgg Medical Inc

$149.7K · #1082/1,925 · 0.0% industry · PY2024

  • TOT $149.7K
  • RANK #1082
  • SHARE 0.0%
  • TXN 647
  • RCP 647
  • CAT 3
  • GEN $149.7K
  • ΔGEN +$11.8K
  • TOP1 6.1%
  • PY 2024

Nearest volume peer: Echosens North America, Inc. ($149.4K)

Talis Clinical LLC$150.9KOne Lambda, Inc.$150.1KCgg Medical Inc (this)$149.7KEchosens North America, Inc.$149.4KUromedica, Incorporated$149.1K
All-tracks payment totals near Cgg Medical Inc (CMS Open Payments PY2024)

Cgg Medical Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Cgg Medical Inc's CMS-reported General Payments increased by $11.8K (+8.5%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: CGG MEDICAL INCPY2023: CGG MEDICAL INCPY2024: Cgg Medical Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$138.0KPY2024$149.7K
PY2023
$137,952.10
PY2024
$149,710.86

What the Data Shows for Cgg Medical Inc

$149,710.86: that is what Cgg Medical Inc reported in payments to 647 physicians and teaching hospitals during Program Year 2024, spread across 647 transactions ($231.39 per transaction, $231.39 per recipient). The company sits at rank #1082 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Travel and Lodging" leads the 3-category general-payment breakdown below at $105.5K (70.5% of General Payments, 142 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Cgg Medical Inc made 3 types of general payments. "Travel and Lodging" is the largest category at $105.5K, 70.5% of General Payments.

How Cgg Medical Inc divides its payments

General-payment categories, ordered by reported total

1. Travel and Lodging$105.5K2. Food and Beverage$37.3K3. Compensation for Services…$6.9K
Payment Type Amount Transactions
Travel and Lodging $105.5K 142
Food and Beverage $37.3K 449
Compensation for Services Other Than Consulting $6.9K 56

Recipient Concentration in General Payments

The five largest recipient relationships account for $32,680.59 (21.8%) of $149,710.86 in this company's General Payments records across 245 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Cgg Medical Inc

The five named recipients with the highest reported General Payments from this company

Steve Jordan$9.2KDavid Oberste$7.3KHector Mejia$6.0KAdam Anz$6.0KJordan Walters$4.2K
  1. 1

    Steve Jordan

    $9,178.62 across 12 reported transactions

  2. 2

    David Oberste

    $7,260.86 across 16 reported transactions

  3. 3

    Hector Mejia

    $6,039.26 across 13 reported transactions

  4. 4

    Adam Anz

    $5,982.19 across 7 reported transactions

  5. 5

    Jordan Walters

    $4,219.66 across 11 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Cgg Medical Inc's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Cgg Medical Inc.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Cgg Medical Inc.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Cgg Medical Inc's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.